Paramount Global has held internal discussions about establishing a board to safeguard CNN’s editorial independence, according to sources familiar with the matter. The move comes as part of broader conversations about the future structure of the network amid ongoing media industry consolidation. No final decisions have been made, and talks remain at an early stage.
The proposed board would be designed to shield CNN from political and commercial pressures, a concern that has intensified as ownership of major news outlets becomes increasingly concentrated. Paramount, which owns CBS, has been exploring strategic options for its assets, including potential partnerships or divestitures. CNN’s current parent company, Warner Bros. Discovery, has not commented on the discussions.
Separately, Eli Lilly has raised alarms over the sale of counterfeit versions of its weight loss drugs on the black market. The pharmaceutical company has warned that unauthorized sellers are offering products that may be unsafe or ineffective. These knockoffs could pose serious health risks to consumers who seek cheaper alternatives to approved medications.
Lilly is urging regulators and law enforcement to crack down on these illegal sales channels. The company has also advised patients to only purchase drugs through verified pharmacies and to consult healthcare providers before starting any treatment. The warning highlights the growing challenge of counterfeit pharmaceuticals in the age of online marketplaces.
In the shipping industry, skepticism surrounds former President Trump’s recent claims about the Strait of Hormuz. Trump suggested that U.S. naval forces have effectively secured the critical waterway, but shippers and industry analysts are not convinced. They point to ongoing threats from regional forces and the lack of a comprehensive security framework in the area.
Maritime experts note that despite increased U.S. military presence, insurance rates for vessels transiting the strait remain elevated. Many shipping companies are still rerouting cargo to avoid the region, a costly adjustment that reflects lingering uncertainty. The discrepancy between official statements and on-the-ground realities underscores the challenges of navigating geopolitical risk in global trade.
These developments come as markets react to a mix of corporate governance issues, public health concerns, and geopolitical tensions. Investors are closely monitoring how companies navigate these intertwined risks. The outcome of Paramount’s discussions could set a precedent for how media companies address editorial independence in a consolidating industry. Meanwhile, the pharmaceutical and shipping sectors continue to grapple with external threats that test their operational resilience.
